These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 36533345)

  • 81. Detailed analysis of the association between urate deposition and bone erosion in gout: a dual-energy computed tomography study.
    Zheng WY; Zhan WF; Wang JY; Deng WM; Hung YK; Wang W; Jiang GH
    Front Endocrinol (Lausanne); 2023; 14():1167756. PubMed ID: 37143721
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Age, Body Mass Index, and Gender Predict 24-Hour Urine Parameters in Recurrent Idiopathic Calcium Oxalate Stone Formers.
    Otto BJ; Bozorgmehri S; Kuo J; Canales M; Bird VG; Canales B
    J Endourol; 2017 Dec; 31(12):1335-1341. PubMed ID: 29084490
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Evidence for abnormal linkage between urine oxalate and citrate excretion in human kidney stone formers.
    Prochaska ML; Moe OW; Asplin JR; Coe FL; Worcester EM
    Physiol Rep; 2021 Jul; 9(13):e14943. PubMed ID: 34231328
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Contributory metabolic factors in the development of nephrolithiasis in patients with medullary sponge kidney.
    Yagisawa T; Kobayashi C; Hayashi T; Yoshida A; Toma H
    Am J Kidney Dis; 2001 Jun; 37(6):1140-3. PubMed ID: 11382681
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Serum and 24-hour urinary tests cost-effectiveness in stone formers.
    Mohammadi A; Farabi H; Baghdadabad LZ; Narouie B; Reis LO; Aghamir SMK
    BMC Urol; 2023 Aug; 23(1):141. PubMed ID: 37635222
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Effect of potential renal acid load of foods on urinary citrate excretion in calcium renal stone formers.
    Trinchieri A; Lizzano R; Marchesotti F; Zanetti G
    Urol Res; 2006 Feb; 34(1):1-7. PubMed ID: 16425021
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Daily Green Tea Infusions in Hypercalciuric Renal Stone Patients: No Evidence for Increased Stone Risk Factors or Oxalate-Dependent Stones.
    Rode J; Bazin D; Dessombz A; Benzerara Y; Letavernier E; Tabibzadeh N; Hoznek A; Tligui M; Traxer O; Daudon M; Haymann JP
    Nutrients; 2019 Jan; 11(2):. PubMed ID: 30678344
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Urinary excretion of uricine.
    Pinto B; Rocha E
    Invest Urol; 1977 Sep; 15(2):155-7. PubMed ID: 20424
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Evaluation of factors involved in calcium stone formation.
    Abraham PA; Smith CL
    Miner Electrolyte Metab; 1987; 13(3):201-8. PubMed ID: 3627051
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Differentiating calcium oxalate and hydroxyapatite stones in vivo using dual-energy CT and urine supersaturation and pH values.
    Liu Y; Qu M; Carter RE; Leng S; Ramirez-Giraldo JC; Jaramillo G; Krambeck AE; Lieske JC; Vrtiska TJ; McCollough CH
    Acad Radiol; 2013 Dec; 20(12):1521-5. PubMed ID: 24200478
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Urinary stone analysis and clinical characteristics of 496 patients in Taiwan.
    Cheng WY; Tseng JS
    Sci Rep; 2024 Jun; 14(1):14115. PubMed ID: 38898140
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Stone composition as a function of age and sex.
    Lieske JC; Rule AD; Krambeck AE; Williams JC; Bergstralh EJ; Mehta RA; Moyer TP
    Clin J Am Soc Nephrol; 2014 Dec; 9(12):2141-6. PubMed ID: 25278549
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Optimum nutrition for kidney stone disease.
    Heilberg IP; Goldfarb DS
    Adv Chronic Kidney Dis; 2013 Mar; 20(2):165-74. PubMed ID: 23439376
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Dual-Source Dual-Energy CT in Detection and Characterization of Urinary Stones in Patients With Large Body Habitus: Observations in a Large Cohort.
    Kordbacheh H; Baliyan V; Uppot RN; Eisner BH; Sahani DV; Kambadakone AR
    AJR Am J Roentgenol; 2019 Apr; 212(4):796-801. PubMed ID: 30673342
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Interconversion of stone composition profiles from two recurrent stone episodes in stone formers.
    Zeng G; Zhao Z; Wu W; Ou L; Liang Y; Yuan J
    Clin Chem Lab Med; 2014 Jul; 52(7):1019-24. PubMed ID: 24633751
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Long-term treatment of calcium nephrolithiasis with potassium citrate.
    Pak CY; Fuller C; Sakhaee K; Preminger GM; Britton F
    J Urol; 1985 Jul; 134(1):11-9. PubMed ID: 3892044
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Role of dual-source dual-energy computed tomography versus X-ray crystallography in prediction of the stone composition: a retrospective non-randomized pilot study.
    Akand M; Koplay M; Islamoglu N; Gul M; Kilic O; Erdogdu MB
    Int Urol Nephrol; 2016 Sep; 48(9):1413-20. PubMed ID: 27206412
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Potassium citrate vs. hydrochlorothiazide to reduce urinary calcium excretion in calcium oxalate stone patients with hypercalciuria: a prospective randomized study.
    Solak V; Gökce Mİ; Yaman Ö
    Int Urol Nephrol; 2021 Sep; 53(9):1791-1796. PubMed ID: 33904027
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Changes in urinary stone risk factors in hypocitraturic calcium oxalate stone formers treated with dietary sodium supplementation.
    Stoller ML; Chi T; Eisner BH; Shami G; Gentle DL
    J Urol; 2009 Mar; 181(3):1140-4. PubMed ID: 19152919
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Ammonium acid urate crystal formation in adult North American stone-formers.
    Pichette V; Bonnardeaux A; Cardinal J; Houde M; Nolin L; Boucher A; Ouimet D
    Am J Kidney Dis; 1997 Aug; 30(2):237-42. PubMed ID: 9261035
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.